BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 19261691)

  • 1. Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines.
    Kondo T; Takiguchi M
    Int Immunol; 2009 May; 21(5):523-32. PubMed ID: 19261691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells.
    Kondo T; Takata H; Takiguchi M
    Eur J Immunol; 2007 Jan; 37(1):54-65. PubMed ID: 17171755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3.
    Kobayashi N; Kondo T; Takata H; Yokota S; Takiguchi M
    J Leukoc Biol; 2006 Aug; 80(2):320-9. PubMed ID: 16861617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation.
    Kobayashi N; Takata H; Yokota S; Takiguchi M
    Eur J Immunol; 2004 Dec; 34(12):3370-8. PubMed ID: 15549771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human late memory CD8+ T cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production.
    Kim TK; St John LS; Wieder ED; Khalili J; Ma Q; Komanduri KV
    J Immunol; 2009 Nov; 183(10):6167-74. PubMed ID: 19841187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
    Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
    Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR5+ CCR7- CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles.
    Quigley MF; Gonzalez VD; Granath A; Andersson J; Sandberg JK
    Eur J Immunol; 2007 Dec; 37(12):3352-62. PubMed ID: 18000950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10.
    Moed H; Boorsma DM; Stoof TJ; von Blomberg BM; Bruynzeel DP; Scheper RJ; Gibbs S; Rustemeyer T
    Br J Dermatol; 2004 Jul; 151(1):32-41. PubMed ID: 15270870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
    Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
    J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
    Shimauchi T; Imai S; Hino R; Tokura Y
    Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function.
    Tomiyama H; Takata H; Matsuda T; Takiguchi M
    Eur J Immunol; 2004 Apr; 34(4):999-1010. PubMed ID: 15048710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation.
    Viallard JF; Blanco P; André M; Etienne G; Liferman F; Neau D; Vidal E; Moreau JF; Pellegrin JL
    Clin Immunol; 2006 Apr; 119(1):51-8. PubMed ID: 16413828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.
    Kondo T; Takata H; Matsuki F; Takiguchi M
    J Immunol; 2009 Feb; 182(4):1794-8. PubMed ID: 19201830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.
    Iellem A; Colantonio L; D'Ambrosio D
    Eur J Immunol; 2003 Jun; 33(6):1488-96. PubMed ID: 12778466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral CD4+CD8+cells are the activated T cells expressed granzyme B (GrB), Foxp3, interleukin 17 (IL-17), at higher levels in Th1/Th2 cytokines.
    Xie D; Hai B; Xie X; Liu L; Ayello J; Ma X; Zhang J
    Cell Immunol; 2009; 259(2):157-64. PubMed ID: 19616200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.
    Campbell JJ; Haraldsen G; Pan J; Rottman J; Qin S; Ponath P; Andrew DP; Warnke R; Ruffing N; Kassam N; Wu L; Butcher EC
    Nature; 1999 Aug; 400(6746):776-80. PubMed ID: 10466728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
    Flytlie HA; Hvid M; Lindgreen E; Kofod-Olsen E; Petersen EL; Jørgensen A; Deleuran M; Vestergaard C; Deleuran B
    Cytokine; 2010 Jan; 49(1):24-9. PubMed ID: 19942450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
    Takata H; Takiguchi M
    J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
    Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
    Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.